{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "P",
          "position": 30
        },
        "variant_string_id": "SNCA A30P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The protein α-synuclein, a 140 amino acid protein of unknown biological function that is mainly distributed in the brain, is the major protein component of Lewy bodies (LWB), the morphological hallmark of Parkinson’s disease (PD). This protein can be conceptualized as containing three regions: (1) the amphipathic N-terminal (1-60); (2) the highly hydrophobic nonamyloid β component (NAC, 61-95) responsible for the high propensity of the peptide to form amyloid fibrils; and (3) the acidic C-terminal (96-140), which enables the protein’s solubility in aqueous solution. Three independent mutations, A53T, A30P, and E46K, are linked to the familial early onset of PD, and so, it is generally hypothesized that α-synuclein plays a critical role in the pathogenesis of this disease.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving α-synuclein and its role in Parkinson’s disease, particularly highlighting the significance of the A30P mutation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The binding of Cu(II) to α-synuclein has been examined by several research groups. It has not been established whether the specific mutations in α-synuclein associated with the familial onset of PD exhibit different Cu(II) binding properties. In the present study, we used isothermal titration calorimetry (ITC) to study the thermodynamics of binding of Cu(II) to WT α-synuclein and two mutants, A53T and A30P, at near-physiological conditions (37 °C, pH 7.4 or 7.2, and an ionic strength of 0.16 M).",
          "judgment": "Yes",
          "reasoning": "ITC is a widely accepted method for studying protein-metal interactions, and the paper uses this method to assess the binding properties of Cu(II) to α-synuclein and its mutants, which is relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The titrations were conducted in PIPES buffer because this buffer species has a negligible binding affinity with Cu(II). All of the solutions were degassed at 37 °C for 15 min prior to titration. The titration was performed as follows. The reaction cell contained ~70-90 µM α-synuclein solution in PIPES buffer. The copper solution, the titrant, was made from the stock copper solution to a concentration such that the molar ratio of Cu(II) to α-synuclein at the end of the titration was ~2 to obtain a good curve for data analysis.",
          "judgment": "Yes",
          "reasoning": "The paper describes the inclusion of appropriate controls (wild-type α-synuclein) and multiple replicates (two runs for each condition with deviations within 10%)."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Two Cu(II) binding constants are observed for A30P. The binding constant for the major binding in A30P is slightly lower (~30% lower) than that of WT and A53T under the same conditions. The different conformational changes of A30P upon Cu(II) association are proposed to contribute to the slightly lower binding affinity of A30P as compared to WT or A53T. In addition to this major binding, there exists a minor but strong Cu(II) binding site (10^10 M^-1) for A30P, which is attributed to the binding to small oligomeric species, present in solution in slow equilibrium with monomer protein.",
          "judgment": "Yes",
          "reasoning": "The statistical analyses in the paper provide sufficient evidence to interpret the functional impact of the A30P mutation on Cu(II) binding affinity and conformational changes."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_moderate"
      },
      "overall_conclusion": "The A30P mutation in SNCA shows a reduced Cu(II) binding affinity and altered conformational changes, which are consistent with its role in the pathogenesis of Parkinson's disease. The functional evidence supports a moderate pathogenic classification."
    },
    {
      "variant_id": {
        "Gene": "SNCA",
        "Protein_Change": {
          "ref": "A",
          "alt": "T",
          "position": 53
        },
        "variant_string_id": "SNCA A53T"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The protein α-synuclein, a 140 amino acid protein of unknown biological function that is mainly distributed in the brain, is the major protein component of Lewy bodies (LWB), the morphological hallmark of Parkinson’s disease (PD). This protein can be conceptualized as containing three regions: (1) the amphipathic N-terminal (1-60); (2) the highly hydrophobic nonamyloid β component (NAC, 61-95) responsible for the high propensity of the peptide to form amyloid fibrils; and (3) the acidic C-terminal (96-140), which enables the protein’s solubility in aqueous solution. Three independent mutations, A53T, A30P, and E46K, are linked to the familial early onset of PD, and so, it is generally hypothesized that α-synuclein plays a critical role in the pathogenesis of this disease.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism involving α-synuclein and its role in Parkinson’s disease, particularly highlighting the significance of the A53T mutation."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The binding of Cu(II) to α-synuclein has been examined by several research groups. It has not been established whether the specific mutations in α-synuclein associated with the familial onset of PD exhibit different Cu(II) binding properties. In the present study, we used isothermal titration calorimetry (ITC) to study the thermodynamics of binding of Cu(II) to WT α-synuclein and two mutants, A53T and A30P, at near-physiological conditions (37 °C, pH 7.4 or 7.2, and an ionic strength of 0.16 M).",
          "judgment": "Yes",
          "reasoning": "ITC is a widely accepted method for studying protein-metal interactions, and the paper uses this method to assess the binding properties of Cu(II) to α-synuclein and its mutants, which is relevant to the disease mechanism."
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "extracted_paper_info": "The titrations were conducted in PIPES buffer because this buffer species has a negligible binding affinity with Cu(II). All of the solutions were degassed at 37 °C for 15 min prior to titration. The titration was performed as follows. The reaction cell contained ~70-90 µM α-synuclein solution in PIPES buffer. The copper solution, the titrant, was made from the stock copper solution to a concentration such that the molar ratio of Cu(II) to α-synuclein at the end of the titration was ~2 to obtain a good curve for data analysis.",
          "judgment": "Yes",
          "reasoning": "The paper describes the inclusion of appropriate controls (wild-type α-synuclein) and multiple replicates (two runs for each condition with deviations within 10%)."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Cu(II) binds to WT and A53T at 37 °C is similar with a pH-dependent binding constant (K) of ~2.4 × 10^9 and ~4.8 × 10^9 M^-1 at pH 7.2 and 7.4, respectively. Cu(II) binding to A30P, however, exhibits two binding constants. The major binding site of A30P, characteristic of >90% of the bound Cu(II), has binding constants of 1.6 × 10^9 and 3.6 × 10^9 M^-1 at pH 7.2 and 7.4, respectively, slightly lower (~70%) than that characteristic of WT or A53T at the corresponding pH.",
          "judgment": "Yes",
          "reasoning": "The statistical analyses in the paper provide sufficient evidence to interpret the functional impact of the A53T mutation on Cu(II) binding affinity, showing no significant difference from wild-type α-synuclein."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_supporting"
      },
      "overall_conclusion": "The A53T mutation in SNCA does not significantly alter Cu(II) binding affinity compared to wild-type α-synuclein, suggesting a supporting role in the pathogenesis of Parkinson's disease. The functional evidence supports a supporting pathogenic classification."
    }
  ]
}